These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17162918)

  • 1. Corneal neovascularization suppressed by TIMP2 released from human amniotic membranes.
    Ma X; Li J
    Yan Ke Xue Bao; 2005 Mar; 21(1):56-61. PubMed ID: 17162918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Suppression of corneal neovascularization by conditioned culture medium of human amniotic membrane].
    Ma X; Bazan H; Li J
    Zhonghua Yan Ke Za Zhi; 2003 Dec; 39(12):753-6. PubMed ID: 14769230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of corneal neovascularization by culture supernatant of human amniotic cells.
    Kobayashi N; Kabuyama Y; Sasaki S; Kato K; Homma Y
    Cornea; 2002 Jan; 21(1):62-7. PubMed ID: 11805510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
    Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the effects of recombinant human epidermal growth factor and basic fibroblast growth factor on corneal epithelial wound healing and neovascularization in vivo and in vitro.
    Yan L; Wu W; Wang Z; Li C; Lu X; Duan H; Zhou J; Wang X; Wan P; Song Y; Tang J; Han Y
    Ophthalmic Res; 2013; 49(3):150-60. PubMed ID: 23258255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
    Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effect of amniotic membrane-fibrin sealant cement on severe ocular surface alkali burn in rabbits].
    Li NY; Zhang WJ; Hu ZL
    Zhonghua Yan Ke Za Zhi; 2022 Aug; 58(8):606-614. PubMed ID: 35959605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of corneal neovascularization by rapamycin.
    Kwon YS; Kim JC
    Exp Mol Med; 2006 Apr; 38(2):173-9. PubMed ID: 16672771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of corneal neovascularization by PEDF release from human amniotic membranes.
    Shao C; Sima J; Zhang SX; Jin J; Reinach P; Wang Z; Ma JX
    Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1758-62. PubMed ID: 15161837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization.
    Cano Mdel V; Karagiannis ED; Soliman M; Bakir B; Zhuang W; Popel AS; Gehlbach PL
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3840-5. PubMed ID: 19279315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.
    Zheng Y; Gu Q; Xu X
    Acta Ophthalmol; 2012 Nov; 90(7):e512-23. PubMed ID: 22994140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amniotic membrane suspension in human corneal wound healing in vitro.
    Choi JA; Jin HJ; Jung S; Yang E; Choi JS; Chung SH; Joo CK
    Mol Vis; 2009 Nov; 15():2230-8. PubMed ID: 19907665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of pathological corneal neovascularization by a small peptide derived from human apolipoprotein (a) Kringle V.
    Wang Z; Zhao H; Ma JX; Xu X
    Cornea; 2014 Apr; 33(4):405-13. PubMed ID: 24452210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Amniotic Membrane Suspension (AMS) and Amniotic Membrane Homogenate (AMH) on Human Corneal Epithelial Cell Viability, Migration and Proliferation In Vitro.
    Wu MF; Stachon T; Langenbucher A; Seitz B; Szentmáry N
    Curr Eye Res; 2017 Mar; 42(3):351-357. PubMed ID: 27420558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro inhibitory effect of amniotic extraction on neovascularization.
    Jiang A; Li C; Gao Y; Zhang M; Hu J; Kuang W; Hao S; Yang W; Xu C; Gao G; Wang Z; Liu Z
    Cornea; 2006 Dec; 25(10 Suppl 1):S36-40. PubMed ID: 17001191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo.
    Bian F; Zhang MC; Zhu Y
    Ophthalmologica; 2008; 222(3):178-86. PubMed ID: 18497527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cryopreservation on anti-cancer activity of human amniotic membrane.
    Modaresifar K; Azizian S; Zolghadr M; Moravvej H; Ahmadiani A; Niknejad H
    Cryobiology; 2017 Feb; 74():61-67. PubMed ID: 27956223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antiangiogenic activity in ex vivo expanded human limbocorneal epithelial cells cultivated on human amniotic membrane.
    Ma DH; Yao JY; Yeh LK; Liang ST; See LC; Chen HT; Lin KY; Liang CC; Lin KK; Chen JK
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2586-95. PubMed ID: 15277481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential anti-angiogenic role of Slit2 in corneal neovascularization.
    Han X; Zhang MC
    Exp Eye Res; 2010 Jun; 90(6):742-9. PubMed ID: 20298689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.